Medtronic Comprehensive Income Attributable to Noncontrolling Interests increased by 133.3% to $7.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $7.00M to $7.00M.
tmo_comprehensive_income_attributable_to_nci| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $5.00M | $4.00M | $0.00 | $6.00M | $11.00M | $6.00M | $0.00 | $17.00M | $6.00M | $9.00M | $7.00M | $8.00M | $3.00M | $7.00M |
| QoQ Change | — | +25.0% | -20.0% | -100.0% | — | +83.3% | -45.5% | -100.0% | — | -64.7% | +50.0% | -22.2% | +14.3% | -62.5% | +133.3% |
| YoY Change | — | — | — | -100.0% | +20.0% | +175.0% | — | -100.0% | +54.5% | +0.0% | — | -58.8% | +33.3% | -66.7% | +0.0% |